keryx

  1. H

    Why the keryx is not running on windows?

    I followed exactly this link http://keryxproject.org/download/keryx-1-0/ But whenever I tried to follow this line "Next, download the Keryx source, extract it, and run the bin/keryx script", a script window is opening and it's closing down. I just want to do the following things. I have an...
  2. T

    Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A

    Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data...
  3. T

    Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A

    Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data...
  4. T

    Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A

    Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data...
  5. T

    Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A

    Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data...
  6. T

    Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A

    Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) (the "Company") announced that an article entitled "Clinical and Translational Studies of a Phase II Trial of the Novel Oral Akt Inhibitor Perifosine in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia," reporting Phase 2 data...
Back
Top